InvestorsHub Logo
Followers 467
Posts 26909
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 172

Friday, 02/07/2014 8:53:08 AM

Friday, February 07, 2014 8:53:08 AM

Post# of 228
7:07AM PDL BioPharma prices $260.87 mln aggregate principal amount of its 4.00% Convertible Senior Notes due Feb 1, 2018 in an underwritten public offering (PDLI) 7.97 : The conversion rate of the Notes will initially be 109.1048 shares of common stock per $1,000 principal amount of the Notes equivalent to an initial conversion price of ~ $9.17 per share of common stock.